Thompson Jaye — SEC Form 4 filings

SEC reporting owner CIK 1476971. 5 Form 4 filings on record with FilingPulse; latest filed 2024-12-27.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-07-22 to 2024-12-27. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Greenwich LifeSciences, Inc. (GLSI)VP Clinical Reg Affairs54 legs · 3,800 sh · $55,1401

Form 4 filings — Thompson Jaye

FiledFormIssuerReported transactionsSource
2024-12-274Greenwich LifeSciences, Inc. (GLSI)Grant/award (A): 149,818 (derivative) @ $0EDGAR
2024-11-254Greenwich LifeSciences, Inc. (GLSI)Purchase (P): 1,000 @ $12.91EDGAR
2024-09-164Greenwich LifeSciences, Inc. (GLSI)Purchase (P): 800 @ $13.85EDGAR
2024-08-054Greenwich LifeSciences, Inc. (GLSI)Purchase (P): 1,000 @ $15.15EDGAR
2024-07-224Greenwich LifeSciences, Inc. (GLSI)Purchase (P): 1,000 @ $16EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1476971 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →